The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Mylan; SERVIER
Durvalumab (D) plus tremelimumab (T) immunotherapy in patients (Pts) with advanced biliary tract carcinoma (BTC) after failure of platinum-based chemotherapy (CTx): Interim results of the IMMUNOBIL GERCOR D18-1 PRODIGE-57 study.
 
Matthieu Delaye
No Relationships to Disclose
 
Eric Assenat
Consulting or Advisory Role - AAA HealthCare; AstraZeneca; Bayer; Ipsen; Roche
 
Laetitia Dahan
Honoraria - AMGEN; BMS; MYLAN; OSEUS; SERVIER
 
Jean-Frédéric Blanc
No Relationships to Disclose
 
David Tougeron
Honoraria - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Merck Serono; MSD; Roche; Sanofi; Servier/Pfizer
Consulting or Advisory Role - AstraZeneca; MSD; Pierre Fabre; Sanofi
Research Funding - AstraZeneca (Inst); BTG (Inst); MSD (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Sanofi
 
Jean-Philippe Metges
Honoraria - BMS; Lilly; Novartis; Sanofi; SynCoreBio
Travel, Accommodations, Expenses - Amgen; Amgen; LEO Pharma; MSD Oncology; MSD Oncology; MSD Oncology
 
Astrid Lievre
Honoraria - Advanced Accelerator Applications; Amgen; Bayer; Bristol-Myers Squibb (Mexico); Incyte; Ipsen; LEO Pharma; Mylan; Novartis; Pierre Fabre; Roche; SERVIER; Viatris
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bristol-Myers Squibb (Mexico); Incyte; Pierre Fabre; SERVIER
Research Funding - Bayer (Inst); IntegraGen (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Ipsen; MSD Oncology; Mylan; Pierre Fabre; Roche; SERVIER
 
Anthony Turpin
No Relationships to Disclose
 
Nadim Fares
Consulting or Advisory Role - Amgen; Bayer; Ipsen; Roche; SERVIER
Travel, Accommodations, Expenses - Ipsen; SERVIER
 
Christelle De La Fouchardiere
Honoraria - Merck Serono; Merck Serono; Roche; Roche
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Eisai; Incyte; Ipsen; Lilly; MSD Oncology; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Ipsen
Research Funding - Pierre Fabre (Inst); Roche; Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Bristol-Myers Squibb; Celgene; Roche; Roche; Roche; SERVIER
Other Relationship - Incyte; MSD Oncology
 
Hélène Castanie
No Relationships to Disclose
 
Jérôme Desrame
Expert Testimony - Roche
Travel, Accommodations, Expenses - Hospira
 
Anna Pellat
No Relationships to Disclose
 
Thierry Lecomte
Consulting or Advisory Role - Amgen; Amgen; AstraZeneca; IPSEN; Merck Serono; Pierre Fabre; Sanofi; Sanofi; SERVIER
Travel, Accommodations, Expenses - Ipsen; Servier/Pfizer
 
Anne Laure Bignon
Honoraria - IPSEN; SANOFI
Travel, Accommodations, Expenses - IPSEN
 
Vincent Hautefeuille
Honoraria - Advanced Accelerator Applications; Amgen; Ipsen; Merck KGaA; Novartis; Sanofi; SERVIER
Research Funding - Ipsen
Travel, Accommodations, Expenses - Amgen; Ipsen; Novartis; Pfizer; Sanofi
 
Marie-Line Garcia-Larnicol
No Relationships to Disclose
 
Antoine Falcoz
No Relationships to Disclose
 
Meher Ben Abdelghani
No Relationships to Disclose
 
Cindy Neuzillet
Honoraria - Amgen; AstraZeneca; Baxter; Bristol-Myers Squibb; Fresenius Kabi; Incyte; Merck; MSD Oncology; Mylan; Novartis; Nutricia; Pierre Fabre; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Incyte
Research Funding - AstraZeneca (Inst); Fresenius Kabi (Inst); Nutricia (Inst); OSE Immunotherapeutics (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Merck; MSD Oncology; Mylan; OSE Immunotherapeutics